Future directions of drug-eluting stents
Journal of Interventional Cardiology: an international forum for global cardiovascular therapies , Volume 22 - Issue SUPPL. 1
Coronary artery stents have changed the face of interventional cardiology since their introduction in 1986. The commercial release of drug-eluting stents in 2002 promised to abolish in-stent restenosis as the predominant clinical limitation following stent implantation. Concerns raised about increased risks of adverse events with drug-eluting stents now appear unfounded but have heralded a new era of research, where only hard clinical end-points in sufficiently large numbers of patients are considered adequate. In this review, we highlight some of the potential future directions of drug-eluting stents including specialized stent platforms (including dedicated bifurcation stents), fully degradable stents, and the potential use of stents to prevent cardiac events.
|Journal of Interventional Cardiology: an international forum for global cardiovascular therapies
|Erasmus MC: University Medical Center Rotterdam
Kukreja, N., Onuma, Y., & Serruys, P. (2009). Future directions of drug-eluting stents. Journal of Interventional Cardiology: an international forum for global cardiovascular therapies (Vol. 22). doi:10.1111/j.1540-8183.2009.00455.x